Feb 12 • 18:48 UTC 🇧🇷 Brazil Folha (PT)

Anvisa suspends batches of Nestlé infant formula; brand says it was a technical error

Anvisa suspends several batches of Nestlé's Alfamino infant formula due to excess levels of selenium and iodine, which the company attributes to a technical error in reporting.

Anvisa, Brazil's National Health Surveillance Agency, has mandated the recall and suspension of ten batches of Nestlé's Alfamino infant formula due to detected levels of selenium and iodine that exceed legal limits. The permissible limit for selenium is 9 µg/100 kcal, yet the analysis indicated a level of 31.1 µg/100 kcal. Similarly, the iodine levels were found to be 175.7 µg/100 kcal, significantly over the allowable limit of 60 µg/100 kcal. Consumption of such excess amounts can lead to gastric and thyroid problems, raising health concerns for infants consuming this formula.

In response, Nestlé has stated that the issue was a result of a unit conversion mistake in the assessment report submitted to Anvisa. The correct levels are actually 3.11 µg/100 kcal for selenium and 17.57 µg/100 kcal for iodine, which are well within the safety limits. The company's assertion emphasizes its commitment to meeting regulatory standards and the safety of its products, suggesting that the swift action taken by Anvisa was unwarranted based on the provided data.

This incident highlights the ongoing scrutiny of food safety standards and regulatory compliance in Brazil, particularly concerning products meant for vulnerable populations like infants. As Anvisa continues to uphold consumer safety, the case also brings to light the challenges faced by food manufacturers in adhering to stringent regulations and communicating effectively with regulatory bodies. Nestlé's response is likely to impact its reputation and consumer trust, both of which are critical in the food industry.

📡 Similar Coverage